| 注册
首页|期刊导航|中国癌症杂志|2025年中国乳腺癌基础转化研究进展与展望

2025年中国乳腺癌基础转化研究进展与展望

车相贤 谢亦璠 王晗 江一舟

中国癌症杂志2026,Vol.36Issue(2):95-101,7.
中国癌症杂志2026,Vol.36Issue(2):95-101,7.DOI:10.19401/j.cnki.1007-3639.2026.02.001

2025年中国乳腺癌基础转化研究进展与展望

Progress and outlook of fundamental and translational breast cancer research in China,2025

车相贤 1谢亦璠 1王晗 1江一舟1

作者信息

  • 1. 复旦大学附属肿瘤医院乳腺外科/复旦大学乳腺癌研究所,复旦大学上海医学院肿瘤学系,上海 200032
  • 折叠

摘要

Abstract

Breast cancer is a highly heterogeneous malignancy.Its initiation,progression,therapeutic response,and risk of recurrence are jointly regulated by intrinsic molecular characteristics of tumor cells,dynamic remodeling of the tumor microenvironment,and multilayered systemic macroenvironmental factors.With the rapid development of single-cell sequencing and spatial omics,breast cancer research has gradually shifted from static classification to a dynamic and systems-level understanding centered on tumor evolution.In 2025,Chinese researchers achieved a series of internationally influential advances in elucidating tumor evolutionary mechanisms,innovating therapeutic strategies,and developing diagnostic and predictive approaches for breast cancer.These studies systematically uncovered novel mechanisms underlying intrinsic adaptive evolution and immune evasion of tumor cells,and further extended the conceptual framework to systemic macroenvironmental regulation,highlighting the critical roles of cross-organ communication in breast cancer progression and metastasis.At the therapeutic level,multiple strategies targeting metabolic vulnerabilities of tumor cells,reprogramming of the tumor immune microenvironment,and biologically engineered technologies have been proposed and validated,demonstrating substantial translational potential in overcoming therapeutic resistance and enhancing treatment efficacy.In terms of diagnosis and prognosis,emerging approaches,including multimodal integration of imaging and omics data,spatial omics,and dynamic monitoring of circulating tumor DNA,have provided new technical pathways for refined molecular stratification,therapeutic response evaluation,and recurrence risk prediction.This review systematically summarizes representative advances made by Chinese researchers in basic and translational breast cancer research in 2025,integrating findings across tumor evolutionary mechanisms,therapeutic innovations,and diagnostic and predictive methodologies.It aims to present an overarching landscape of the field,distill shared scientific themes,and provide future directions for precision diagnosis,treatment,and individualized longitudinal management of breast cancer.

关键词

乳腺癌/基础转化研究/肿瘤演进/肿瘤微环境/多组学整合

Key words

Breast cancer/Basic and translational research/Tumor evolution/Tumor microenvironment/Multiomics integration

分类

医药卫生

引用本文复制引用

车相贤,谢亦璠,王晗,江一舟..2025年中国乳腺癌基础转化研究进展与展望[J].中国癌症杂志,2026,36(2):95-101,7.

基金项目

上海市教育委员会"曙光计划"项目(24SG12)、国家自然科学基金(82503604). "Dawn"Program of Shanghai Education Commission,China(24SG12) (24SG12)

National Natural Science Foundation of China(82503604). (82503604)

中国癌症杂志

1007-3639

访问量1
|
下载量0
段落导航相关论文